Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

With $100M, startup to bring Lilly-licensed drug into trials
Bizjournals
Thu, 11/11/21 - 11:05 am
Tags:
Acrivon Therapeutics, Eli Lilly, clinical trials
Eli Lilly touts long-term safety data for Olumiant amid classwide scrutiny on JAK meds
Fierce Pharma
Wed, 11/10/21 - 09:39 pm
Tags:
Eli Lilly, olumiant, JAK inhibitors, Pfizer, Xeljanz
Lilly pulls COVID-19 treatment from EU review while U.S. stocks up
Reuters
Wed, 11/3/21 - 11:46 pm
Tags:
Eli Lilly, antibodies, COVID-19, Europe
Judge rules HHS' letter enforcing 340B discounts was 'arbitrary'
Beckers Hospital Review
Tue, 11/2/21 - 11:51 pm
Tags:
HHS, drug pricing, 340B, AstraZeneca, Eli Lilly, Novo Nordisk, Sanofi, United Therapeutics
Eli Lilly serves up a win over Biden's HHS in drug discount court case
Endpoints
Mon, 11/1/21 - 11:02 pm
Tags:
Eli Lilly, Indiana, HHS, Joe Biden, drug discounts
Eli Lilly and Pfizer Put Osteoarthritis Pain Drug Out of its Misery
BioSpace
Wed, 10/27/21 - 11:38 pm
Tags:
Eli Lilly, Pfizer, tanezumab, osteoarthritis
As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth
Fierce Pharma
Tue, 10/26/21 - 11:54 pm
Tags:
Eli Lilly, earnings, Trulicity, Taltz, Verzenio, Emgality
Eli Lilly kick-starts speedy FDA review for Alzheimer's hopeful donanemab—and a one-on-one test against Aduhelm
Fierce Biotech
Tue, 10/26/21 - 10:50 am
Tags:
Eli Lilly, Alzheimer's disease, FDA, donanemab, Biogen, Aduhelm, zagotenemab
Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
Motley Fool
Fri, 10/22/21 - 12:18 pm
Tags:
Merck, COVID-19, molnupiravir, Regeneron, Eli Lilly, antibodies
Eli Lilly ordered to pay royalties on blockbuster diabetes drugs, though exact damages are unclear
Endpoints
Thu, 10/21/21 - 11:22 pm
Tags:
Eli Lilly, Arizona, diabetes, insulin
Could This Be the Next Blockbuster Indication for Eli Lilly?
Motley Fool
Thu, 10/21/21 - 10:37 am
Tags:
Eli Lilly, alopecia areata, olumiant, clinical trials
Lilly's Longest Diabetes Drug Trial Lowers A1C and Increases Weight Loss
BioSpace
Tue, 10/19/21 - 11:53 am
Tags:
Eli Lilly, clinical trials, diabetes, tirzepatide
Good news for Lilly as sintilimab hits the spot in lung cancer again
Pharmaforum
Tue, 10/19/21 - 10:47 am
Tags:
Eli Lilly, China, Innovent, sintilimab, non-squamous non-small cell lung cancer, non-small cell lung cancer
Regeneron, Novo Nordisk, Lilly and AbbVie stake claims on September's list of top TV ad spenders
Fierce Pharma
Mon, 10/18/21 - 10:49 pm
Tags:
Regeneron, Novo Nordisk, Eli Lilly, AbbVie, television ads, DTC ads, diabetes, immunology
Eli Lilly's Verzenio snags first-in-class FDA approval for early breast cancer. But limited label poses a challenge
Fierce Pharma
Wed, 10/13/21 - 11:07 am
Tags:
Eli Lilly, Verzenio, FDA, early breast cancer, breast cancer
Eli Lilly, Boehringer roll out video game for doctors to highlight cardio-renal-metabolic disease connections
Fierce Pharma
Tue, 10/12/21 - 11:41 pm
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, diabetes, gamification
Eli Lilly’s recalled emergency diabetes drug came from plant cited by FDA
Reuters
Tue, 10/5/21 - 09:45 pm
Tags:
Eli Lilly, diabetes, Glucagon Emergency Kits, drug manufacturing, product recalls
Lilly adds liver fat, CGM blood sugar data to mountain of evidence on hot diabetes prospect tirzepatide
Fierce Biotech
Thu, 09/30/21 - 10:58 am
Tags:
Eli Lilly, tirzepatide, clinical trials, diabetes
HHS lines up Novartis, Lilly, AstraZeneca and 3 other drugmakers for fines due to drug discount violations
Endpoints
Fri, 09/24/21 - 12:00 pm
Tags:
HHS, 340B, discounts, Novartis, Eli Lilly, AstraZeneca, Novo Nordisk, Sanofi, United Therapeutics
FDA approves Eli Lilly antibody cocktail for COVID-19 prevention
Beckers Hospital Review
Thu, 09/16/21 - 11:10 pm
Tags:
Eli Lilly, Emergency Use Authorization, COVID-19, antibodies, FDA

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.